In today's news postings is a story about a Chinese biotech firm that has licensed the world-wide rights to a a virus-based treatment for oral cancer. The treatment was first developed by Onyx Pharmaceuticals of California and then abandonned. The Chinese company has picked up development and now, reportedly, has a virus that delivers the p53 gene to tumor cells.
The article is available at:
http://www.oralcancerfoundation.org/news/story.asp?newsId=624 Best, Sheldon
